165 related articles for article (PubMed ID: 35067473)
1. Corrigendum to "Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice" [Int. Immunopharmacol. 102 (2022) 108411].
Hao J; Sun W; Xu H
Int Immunopharmacol; 2022 Mar; 104():108550. PubMed ID: 35067473
[No Abstract] [Full Text] [Related]
2. Corrigendum to "Neuroprotective effect of Vesatolimod in an experimental autoimmune encephalomyelitis mice model" [Int. Immunopharmacol. 116 (2023) 109717].
Jiang X; Song Y; Fang J; Yang X; Mu S; Zhang J
Int Immunopharmacol; 2024 Feb; 128():111448. PubMed ID: 38191277
[No Abstract] [Full Text] [Related]
3. Corrigendum to "HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE)" [Int. Immunopharmacol. 78 (2020) 105943].
Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaeia M; Keyvani H
Int Immunopharmacol; 2020 Nov; 88():106742. PubMed ID: 32805692
[No Abstract] [Full Text] [Related]
4. Corrigendum to "STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance" [Int. Immunopharmacol. 119 (2023) 110160].
Gharibi T; Barpour N; Hosseini A; Mohammadzadeh A; Marofi F; Ebrahimi-Kalan A; Nejati-Koshki K; Abdollahpour-Alitappeh M; Safaei S; Baghbani E; Baradaran B
Int Immunopharmacol; 2023 Jun; 119():110303. PubMed ID: 37179201
[No Abstract] [Full Text] [Related]
5. Corrigendum to "Mangiferin corrects the imbalance of Th17/Treg cells in mice with TNBS-induced colitis" [Int. Immunopharmacol. (2016) 220-228].
Lim SM; Jeong JJ; Choi HS; Chang HB; Kim DH
Int Immunopharmacol; 2016 Sep; 38():468. PubMed ID: 27262502
[No Abstract] [Full Text] [Related]
6. Corrigendum to "Zerumbone enhances the Th1 response and ameliorates ovalbumin-induced Th2 responses and airway inflammation in mice" [Int. Immunopharmacol. 24 (2015) 383-391].
Shieh YH; Huang HM; Ching-Chiung Wang ; Lee CC; Fan CK; Lee YL
Int Immunopharmacol; 2017 Sep; 50():371. PubMed ID: 28751107
[No Abstract] [Full Text] [Related]
7. Corrigendum to "Sodium houttuyfonate enhances the intestinal barrier and attenuates inflammation induced by Salmonella typhimurium through the NF-κB pathway in mice" [Int. Immunopharmacol. 89 (2020) 107058].
Zhang L; Lv H; Li Y; Dong N; Bi C; Shan A; Wu Z; Shi B
Int Immunopharmacol; 2021 Mar; 92():107351. PubMed ID: 33444920
[No Abstract] [Full Text] [Related]
8. Corrigendum to "Protective effect of tormentic acid from Potentilla chinensis against lipopolysaccharide/D-galactosamine induced fulminant hepatic failure in mice" [Int. Immunopharmacol. 19 (2014) 365-372].
Lin X; Zhang S; Huang R; Tan S; Liang S; Wu X; Zhuo L; Huang Q
Int Immunopharmacol; 2021 Jan; 90():107244. PubMed ID: 33309532
[No Abstract] [Full Text] [Related]
9. Corrigendum to "MEGF6 prevents sepsis-induced acute lung injury in mice" [Int. Immunopharmacol. 123 (2023) 110727].
Liang H; Liu G; Zeng W; Fan Q; Nie Z; Hu H; Zhang R; Xie S
Int Immunopharmacol; 2024 May; 133():111787. PubMed ID: 38641473
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Methylallyl sulfone attenuates inflammation, oxidative stress and lung injury induced by cigarette smoke extract in mice and RAW264.7 cells" Int Immunopharmacol, volume 59, 2018, 369-374.
Li A; Liu Y; Zhu X; Sun X; Feng X; Li D; Zhang J; Zhu M; Zhao Z
Int Immunopharmacol; 2019 Jul; 72():522. PubMed ID: 30922802
[No Abstract] [Full Text] [Related]
11. Corrigendum to "Liproxstatin-1 alleviates LPS/IL-13-induced bronchial epithelial cell injury and neutrophilic asthma in mice by inhibiting ferroptosis" [Int. Immunopharmacol. 109 (2022) 108770].
Bao C; Liu C; Liu Q; Hua L; Hu J; Li Z; Xu S
Int Immunopharmacol; 2023 Feb; 115():109482. PubMed ID: 36610897
[No Abstract] [Full Text] [Related]
12. Corrigendum to "Emodin ameliorates ulcerative colitis by the flagellin-TLR5 dependent pathway in mice" [Int. Immunopharmacol. 59 (2018) 269-275].
Luo S; Deng X; Liu Q; Pan Z; Zhao Z; Zhou L; Luo X
Int Immunopharmacol; 2018 Sep; 62():337. PubMed ID: 29983242
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Baicalin suppresses IL-1β-induced expression of inflammatory cytokines via blocking NF-κB in human osteoarthritis chondrocytes and shows protective effect in mice osteoarthritis models" [Int. Immunopharmacol. 52 (2017) 218-226].
Chen C; Zhang C; Cai L; Xie H; Hu W; Wang T; Lu D; Chen H
Int Immunopharmacol; 2021 Jun; 95():107546. PubMed ID: 33735716
[No Abstract] [Full Text] [Related]
14. Corrigendum to "Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function" [Int. Immunopharmacol. (2015) 423-432].
Sun J; Shen X; Dong J; Zhao J; Zuo L; Wang H; Li Y; Zhu W; Gong J; Li J
Int Immunopharmacol; 2016 Jun; 35():341. PubMed ID: 27130814
[No Abstract] [Full Text] [Related]
15. Corrigendum to "4-Hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice" [Int. Immunopharmacol. 83 (2020) 106445].
Wang H; Wei X; Wei X; Sun X; Huang X; Liang Y; Xu W; Zhu X; Lin X; Lin J
Int Immunopharmacol; 2020 Sep; 86():106722. PubMed ID: 32593975
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Asiatic acid inhibits LPS-induced inflammatory response in human gingival fibroblasts" [Int. Immunopharmacol. 50(2017) 313-318].
Hao C; Wu B; Hou Z; Xie Q; Liao T; Wang T; Ma D
Int Immunopharmacol; 2019 Jul; 72():523. PubMed ID: 31080023
[No Abstract] [Full Text] [Related]
17. Corrigendum to "Gallic acid improved inflammation via NF-κB pathway in TNBS-induced ulcerative colitis" [Int. Immunopharmacol. 67 (2019) 129-137].
Zhu L; Gu P; Shen H
Int Immunopharmacol; 2021 Oct; 99():107815. PubMed ID: 34130920
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 99 (2021) 108005].
Mohamed NI; Suddek GM; El-Kashef DH
Int Immunopharmacol; 2022 Apr; 105():108575. PubMed ID: 35115257
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Ghrelin attenuates secondary brain injury following intracerebral hemorrhage by inhibiting NLRP3 inflammasome activation and promoting Nrf2/ARE signaling pathway in mice" [Int. Immunopharmacol. 79 (2020) 106180].
Cheng Y; Chen B; Xie W; Chen Z; Yang G; Cai Y; Shang H; Zhao W
Int Immunopharmacol; 2020 Jul; 84():106461. PubMed ID: 32278662
[No Abstract] [Full Text] [Related]
20. Corrigendum to 'Cordycepin (3'-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination'. [Int. Immunopharmacol. 75 (2019) 105777].
Jia Y; Li H; Bao H; Zhang D; Feng L; Xiao Y; Zhu K; Hou Y; Luo S; Zhang Y; Xiao L; Chen X; Zhou J; Wang C; Wang G; Yu H; Xiao C; Du J
Int Immunopharmacol; 2020 Jan; 78():106033. PubMed ID: 31830623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
